热门资讯> 正文
NeuroMetrics任命新独立董事，终止股权计划;入股
2024-04-19 21:10
- NeuroMetrix (NASDAQ:NURO) Friday announced the appointment of Joshua S. Horowitz as a new independent director with a 1-year term, and terminated its at-the-market equity facility it had entered into with Ladenburg Thalmann & Co.
- The steps follow recommendations from one of its largest shareholders, Ephraim Fields of Echo Lake Capital, NeuroMetrix (NURO) said.
- NURO +10.95% premarket to $4.05.
- Source: Press Release
More on NeuroMetrix
- NeuroMetrix, Inc. (NURO) Q4 2023 Earnings Call Transcript
- Financial information for NeuroMetrix
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
